Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific transdermal drug delivery systems market in 2021

PORTLAND, OREGON, UNITED STATES, January 20, 2022 /EINPresswire.com/ -- According to the report by Allied Market Research, titled, "Transdermal Drug Delivery Systems Market by Type of Delivery System [Passive (Matrix System and Reservoir System), Active [Structure Based, Electrical Based, (Iontophoresis, Electroporation, and Sonophoresis), and Others] and Application (Analgesics, Hormone Replacement Therapy, Cardiovascular Disorders, Motion Sickness, and Smoking Cessation) - Global Opportunity Analysis and Industry Forecast, 2022-2028". The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Innovation in transdermal drug delivery technologies drives the market growth. For instance, companies are developing new adhesives and enhancers that are expected to be delivered through transdermal route, which could enhance skin permeability and thus fuel the market growth.
For Right Perspective and Competitive Insights, Get Sample Report at:

https://www.alliedmarketresearch.com/request-sample/1774

Asia-Pacific is projected to register the highest CAGR of 10.1% during the forecast period, owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (India and China) to cater to the unmet medical needs. Technological advancements to develop cost-effective technologies in these nations offer a lucrative opportunity for the market growth.

Comprehensive competitive analysis and profiles of major market players, such as

The major companies profiled in the report includes Novartis AG, Johnson & Johnson, Mylan N.V., Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc., Acrux Limited, Echo Therapeutics, Inc., and Endo Pharmaceuticals Inc.

KEY FINDINGS OF THE STUDY

• Reservoir system segment is projected to grow at a CAGR of 7.3% during the forecast period.

• Matrix system contributed for nearly two-third share of the global passive transdermal drug delivery systems market, in 2021.

• Structure-based drug delivery system segment is expected to register the highest CAGR of 13.3% during the analysis period.

• Cardiovascular disorders segment is expected to grow at the highest CAGR of 10.8% during the forecast period.

• France and Germany collectively contributed for more than one-third share of the European transdermal drug delivery systems market in 2021.

• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific transdermal drug delivery systems market in 2021.

Table of Content:

CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities…

Get detailed COVID-19 impact analysis@ Request For Customization:-

https://www.alliedmarketresearch.com/request-for-customization/485

FREQUENTLY ASKED QUESTIONS?

Q1. What is the market value of transdermal drug delivery systems market report in forecast period?
Q2. What would be forecast period in the market report?
Q3. What is the market value of transdermal drug delivery systems market in 2021?
Q4. Which is base year calculated in the transdermal drug delivery systems market eport?
Q5. Does the transdermal drug delivery systems Market Company is profiled in the report?
Q6. Which are the top companies hold the market share in transdermal drug delivery systems market?
Q7. Does the transdermal drug delivery systems market report provides Value Chain Analysis?
Q8. What are the key trends in the transdermal drug delivery systems market report?

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.